[1]汪 青,黄昊强,陈 勇,等.基于生物信息学分析二仙汤治疗膝关节骨性关节炎合并骨质疏松症的机制[J].医学信息,2024,37(06):1-6.[doi:10.3969/j.issn.1006-1959.2024.06.001]
　WANG Qing,HUANG Hao-qiang,CHEN Yong,et al.Mechanism of Erxian Decoction in the Treatment of Knee Osteoarthritis with Osteoporosis Based on Bioinformatics Analysis[J].Journal of Medical Information,2024,37(06):1-6.[doi:10.3969/j.issn.1006-1959.2024.06.001]
点击复制

基于生物信息学分析二仙汤治疗膝关节骨性关节炎合并骨质疏松症的机制()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年06期
页码:
1-6
栏目:
生物信息学
出版日期:
2024-03-15

文章信息/Info

Title:
Mechanism of Erxian Decoction in the Treatment of Knee Osteoarthritis with Osteoporosis Based on Bioinformatics Analysis
文章编号:
1006-1959（2024）06-0001-06
作者:
汪 青; 黄昊强; 陈 勇; 等
（昆山市中医医院骨科，江苏 昆山 215300）
Author(s):
WANG Qing; HUANG Hao-qiang; CHEN Yong; et al.
(Department of Orthopaedics,Kunshan Hospital of Traditional Chinese Medicine,Kunshan 215300,Jiangsu,China)
关键词:
生物信息学; 二仙汤; 膝骨性关节炎; 骨质疏松症
Keywords:
Bioinformatics; Erxian decoction; Knee osteoarthritis; Osteoporosis
分类号:
R246.9；R684.3
DOI:
10.3969/j.issn.1006-1959.2024.06.001
文献标志码:
A
摘要:
目的 通过生物信息学的方法探讨二仙汤对于骨质疏松症（OP）及膝关节骨性关节炎（KOA）共病治疗的可能机制，为临床应用提供理论依据。方法 分别以骨质疏松症及膝关节骨性关节炎作为关键词，在Disgenet、TTD、Genecards疾病数据库筛选疾病靶点。在中药数据库平台筛选二仙汤的有效化合物，并通过Netinfer平台预测二仙汤的靶标，Venny2.1.0进行交集，获得二仙汤治疗OP合并KOA的靶点。通过String数据库制作靶点间相互作用PPI网络，并导入cytoscape3.7.2。使用R语言进行GO生物过程富集分析以及KEGG通路富集分析，并进行可视化。结果 筛选OP相关靶点533个，KOA靶点302个，预测二仙汤靶点104个，取三者交集，获得二仙汤治疗OP合并KOA靶点共14个，GO生物学过程富集在炎症反应调节、胶原蛋白分解代谢过程等。KEGG富集在白介素17信号通道，雌激素信号通道等。结论 二仙汤治疗OP合并KOA的主要机制可能是调节炎症因子、调节性激素水平，这为二仙汤进一步的临床应用及机制研究提供了依据。
Abstract:
Objective To explore the possible mechanism of Erxian decoction in the treatment of osteoporosis (OP) and knee osteoarthritis (KOA) by bioinformatics methods, and to provide theoretical basis for clinical application.Methods Osteoporosis and knee osteoarthritis were used as keywords to screen disease targets in Disgenet, TTD and Genecards disease databases. The effective compounds of Erxian decoction were screened on the traditional Chinese medicine database platform, and the target of Erxian decoction was predicted by Netinfer platform. Venny2.1.0 was used for intersection to obtain the target of Erxian decoction in the treatment of OP combined with KOA. The PPI network of interaction between targets was made through the String database and imported into cytoscape 3.7.2. GO biological process enrichment analysis and KEGG pathway enrichment analysis were performed using R language, and visualization was performed.Results A total of 533 OP-related targets, 302 KOA targets, and 104 predicted Erxian decoction targets were screened. The intersection of the three was taken to obtain a total of 14 targets for the treatment of OP combined with KOA by Erxian decoction. GO biological processes were enriched in inflammatory response regulation, collagen catabolic process, etc. KEGG enrichment in interleukin 17 signal channel, estrogen signal channel, etc.Conclusion The main mechanism of Erxian decoction in the treatment of OP combined with KOA may be to regulate inflammatory factors and regulate sex hormone levels, which provides a basis for further clinical application and mechanism research of Erxian decoction.

参考文献/References:

[1]Lin L,Luo P,Yang M,et al.Causal relationship between osteoporosis and osteoarthritis: A two-sample Mendelian randomized study[J].Front Endocrinol(Lausanne),2022,13:1011246.[2]Hudock KM,Collins MS,Imbrogno M,et al.Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia[J].Am J Physiol Lung Cell Mol Physiol,2020,319(1):L137-L147.[3]Bollmann M,Pinno K,Ehnold LI,et al.MMP-9 mediated Syndecan-4 shedding correlates with osteoarthritis severity[J].Osteoarthritis Cartilage,2021,29(2):280-289.[4]Sabry M,Mostafa S,Rashed L,et al.Matrix metalloproteinase 9 a potential major player connecting atherosclerosis and osteoporosis in high fat diet fed rats[J].PLoS One,2021,16(2):e244650.[5]Wang Z,Wei Y,Lei L,et al.RANKL expression of primary osteoblasts is enhanced by an IL-17-mediated JAK2/STAT3 pathway through autophagy suppression[J].Connect Tissue Res,2021,62(4):411-426.[6]Shen Y,Wang Z,Tan J,et al.TRAF6/ERK/p38 pathway is involved in interleukin-17-mediated autophagy to promote osteoclast precursor cell differentiation[J].Journal of Zhejiang University,2021,50(2):162-170.[7]Che ATN,Lau SF,Mohamed S.Ficus deltoidea Prevented Bone Loss in Preclinical Osteoporosis/Osteoarthritis Model by Suppressing Inflammation[J].Calcif Tissue Int,2018,103(4):388-399.[8]Feng W,Yang P,Liu H,et al.IL-6 promotes low concentration of RANKL-induced osteoclastic differentiation by mouse BMMs through trans-signaling pathway[J].J Mol Histol,2022,53(3):599-610.[9]段小凯，秦贵军.绝经女性2型糖尿病患者血清CXC趋化因子配体8、10和Irisin蛋白的表达及意义[J].中国老年学杂志,2019,39(6):1315-1317.[10]Bhadricha H,Patel V,Singh AK,et al.Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women[J].Sci Rep,2021,11(1):16155.[11]Wang K,Xu J,Cai J,et al.Serum levels of resistin and interleukin-17 are associated with increased cartilage defects and bone marrow lesions in patients with knee osteoarthritis[J].Mod Rheumatol,2017,27(2):339-344.[12]Zhang XL,Li J,Zhou XL,et al.Effect of Er-Xian decoction on autoimmune premature ovarian failure in mice[J].J Tradit Chin Med,2021,41(5):725-731.[13]周绵莉,喻小兰,施后渊,等.二仙汤通过AMPK/mTOR通路保护早发性卵巢功能不全小鼠免受氧化应激及凋亡影响[J].世界科学技术-中医药现代化,2022,24(12):4889-4896.[14]Wang N,Xin H,Xu P,et al.Erxian Decoction Attenuates TNF-alpha Induced Osteoblast Apoptosis by Modulating the Akt/Nrf2/HO-1 Signaling Pathway[J].Front Pharmacol,2019,10:988.[15]杨昌文,侯晓强,张辉军.二仙汤治疗老年类风湿关节炎伴骨质疏松的疗效观察[J].中国中医基础医学杂志,2018,24(10):1447-1450.[16]Tan S,Xu J,Lai A,et al.Curculigoside exerts significant anti-arthritic effects in vivo and in vitro via regulation of the JAK/STAT/NF kappaB signaling pathway[J].Mol Med Rep,2019,19(3):2057-2064.[17]Li K,Yu XH,Maskey AR,et al.Cytochrome P450 3A4 suppression by epimedium and active compound kaempferol leads to synergistic anti-inflammatory effect with corticosteroid[J].Front Pharmacol,2022,13:1042756.[18]Luo H,Wang Y,Qin Q,et al.Anti-inflammatory naphthoates and anthraquinones from the roots of Morinda officinalis[J].Bioorg Chem,2021,110:104800.[19]Zai Z,Xu Y,Qian X,et al.Estrogen antagonizes ASIC1a-induced chondrocyte mitochondrial stress in rheumatoid arthritis[J].J Transl Med,2022,20(1):561.[20]Peng X,Qiao Z,Wang Y,et al.Estrogen reverses nicotine-induced inflammation in chondrocytes via reducing the degradation of ECM[J].Int J Rheum Dis,2019,22(4):666-676.[21]Su JW,Li SF,Tao JJ,et al.Estrogen protects against acidosis-mediated articular chondrocyte injury by promoting ASIC1a protein degradation[J].Eur J Pharmacol,2021,908:174381.[22]Lu T,Achari Y,Sciore P,et al.Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site[J].Biochim Biophys Acta,2006,1762(8):719-731.[23]Wang N,Zhang X,Rothrauff BB,et al.Novel role of estrogen receptor-alpha on regulating chondrocyte phenotype and response to mechanical loading[J].Osteoarthritis Cartilage,2022,30(2):302-314.[24]李翠云.二仙汤加减治疗卵巢早衰98例疗效分析[J].实用中医药杂志,2015(7):603-604.[25]项晓觉,孙腾飞,张云霞,等.二仙汤辅助治疗绝经后女性高血压的临床效果及对雌激素和Kupperman评分的影响[J].中国医药导报,2020,17(8):170-173.[26]高畅,李书琪,黄巧,等.二仙汤及其核心组方仙茅-仙灵脾对乳腺增生症大鼠雌孕激素受体通路的影响[J].环球中医药,2019,12(12):1816-1822.

相似文献/References:

[1]杨宵月,李建伟.LncRNA调控人类疾病关系数据库的研究[J].医学信息,2019,32(12):28.[doi:10.3969/j.issn.1006-1959.2019.12.010]
　YANG Xiao-yue,LI Jian-wei.LncRNA Regulation of Human Disease Relationship Database[J].Journal of Medical Information,2019,32(06):28.[doi:10.3969/j.issn.1006-1959.2019.12.010]
[2]操利超,张核子,余晨笛,等.CLDN11在结肠癌中的预后价值及其作为潜在免疫治疗靶点的研究[J].医学信息,2022,35(14):10.[doi:10.3969/j.issn.1006-1959.2022.14.002]
　CAO Li-chao,ZHANG He-zi,YU Chen-di,et al.The Prognostic Value of CLDN11 in Colon Cancer and its Potential Immunotherapy Targets[J].Journal of Medical Information,2022,35(06):10.[doi:10.3969/j.issn.1006-1959.2022.14.002]
[3]王婷婷,温凌杜,王子弘,等.基于DNA甲基化鉴定口腔鳞状细胞癌预后生物标志物[J].医学信息,2022,35(13):28.[doi:10.3969/j.issn.1006-1959.2022.13.005]
　WANG Ting-ting,WEN Ling-du,WANG Zi-hong,et al.Identification of Prognostic Biomarkers for Oral Squamous Cell Carcinoma Based on DNA Methylation[J].Journal of Medical Information,2022,35(06):28.[doi:10.3969/j.issn.1006-1959.2022.13.005]
[4]黄琪峰,郑琳琳,张 菁.甲状腺癌中miR-222关键靶基因预测及其信号通路分析[J].医学信息,2020,33(01):85.[doi:10.3969/j.issn.1006-1959.2020.01.026]
　HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Prediction of Key Target Genes of miR-222 in Thyroid Cancer and Analysis of Its Signal Pathway[J].Journal of Medical Information,2020,33(06):85.[doi:10.3969/j.issn.1006-1959.2020.01.026]
[5]李熹阳,谷明宇,华 琳.影响前列腺癌风险的关键基因识别[J].医学信息,2020,33(02):80.[doi:10.3969/j.issn.1006-1959.2020.02.022]
　LI Xi-yang,GU Ming-yu,HUA Lin.Identification of Key Genes Affecting Prostate Cancer Risk[J].Journal of Medical Information,2020,33(06):80.[doi:10.3969/j.issn.1006-1959.2020.02.022]
[6]黄 成,易尚辉,查文婷,等.基于生物信息学分析筛选舌鳞状细胞癌核心基因及其预后价值[J].医学信息,2020,33(03):6.[doi:10.3969/j.issn.1006-1959.2020.03.002]
　HUANG Cheng,YI Shang-hui,ZHA Wen-ting,et al.Screening Core Genes of Tongue Squamous Cell Carcinoma Based on Bioinformatics Analysis and Its Prognostic Value[J].Journal of Medical Information,2020,33(06):6.[doi:10.3969/j.issn.1006-1959.2020.03.002]
[7]吴超颖,陈 冬,吴超群,等.头颈部鳞状细胞癌预后相关的miRNAs的生物信息学分析[J].医学信息,2020,33(02):61.[doi:10.3969/j.issn.1006-1959.2020.02.017]
　WU Chao-ying,CHEN Dong,WU Chao-qun,et al.Bioinformatics Analysis of Prognosis-related miRNAs in Head and Neck Squamous Cell Carcinoma[J].Journal of Medical Information,2020,33(06):61.[doi:10.3969/j.issn.1006-1959.2020.02.017]
[8]胡昕倩,余雅婕,方 明.垂体瘤的基因芯片数据生物信息学分析[J].医学信息,2020,33(06):90.[doi:10.3969/j.issn.1006-1959.2020.06.026]
　HU Xin-qian,YU Ya-jie,FANG Ming.Bioinformatics Analysis of Gene Chip Data for Pituitary Tumors[J].Journal of Medical Information,2020,33(06):90.[doi:10.3969/j.issn.1006-1959.2020.06.026]
[9]马晓玉,岳欣蕾,韩佳玲,等.蛋白质-适配体相互作用预测的方法[J].医学信息,2020,33(10):27.[doi:10.3969/j.issn.1006-1959.2020.10.008]
　MA Xiao-yu,YUE Xin-lei,HAN Jia-ling,et al.Method for Predicting Protein-aptamer Interaction[J].Journal of Medical Information,2020,33(06):27.[doi:10.3969/j.issn.1006-1959.2020.10.008]
[10]王 淮,杨健康.基于生物信息学分析F13A1基因及蛋白质[J].医学信息,2020,33(11):52.[doi:10.3969/j.issn.1006-1959.2020.11.017]
　WANG Huai,YANG Jian-kang.Analysis of F13A1 Gene and Protein Based on Bioinformatics[J].Journal of Medical Information,2020,33(06):52.[doi:10.3969/j.issn.1006-1959.2020.11.017]

更新日期/Last Update: 1900-01-01